John Saia Biography and Net Worth

Insider of Guardant Health

John Saia is the Chief Legal Officer at Guardant Health, where he oversees the global legal and compliance operations for the company. His prior experience includes nearly three decades serving in leadership roles within two different branches of the US government, in private practice at multinational law firms and as a C-suite level executive at both large and small public companies. Prior to joining Guardant Health, Saia was the SVP, General Counsel and Corporate Secretary at WageWorks, where he was responsible for leading the fintech SaaS provider of consumer-directed benefits with more than 75,000 customers. Saia earned his JD from The George Washington University Law School, and his Bachelor of Science and Bachelor of Arts in Political Science and Economics from Santa Clara University.

What is John G. Saia's net worth?: The estimated net worth of John G. Saia is at least $4.41 million as of November 7th, 2025. Mr. Saia owns 43,172 shares of Guardant Health stock worth more than $4,406,566 as of December 14th. This net worth evaluation does not reflect any other assets that Mr. Saia may own. Additionally, Mr. Saia receives a salary of $627,180.00 as Insider at Guardant Health. Learn More about John G. Saia's net worth.
How old is John G. Saia?: Mr. Saia is currently 51 years old. There are 7 older executives and no younger executives at Guardant Health. The oldest executive at Guardant Health is Mr. Kumud Kalia, Chief Information Officer, who is 58 years old. Learn More on John G. Saia's age.
What is John G. Saia's salary?: As the Insider of Guardant Health, Inc., Mr. Saia earns $627,180.00 per year. There are 3 executives that earn more than Mr. Saia. The highest earning executive at Guardant Health is Dr. Craig Eagle M.D., Chief Medical Officer, who commands a salary of $649,130.00 per year. Learn More on John G. Saia's salary.
How do I contact John G. Saia?: The corporate mailing address for Mr. Saia and other Guardant Health executives is 505 PENOBSCOT DR., REDWOOD CITY CA, 94063. Guardant Health can also be reached via phone at (855) 698-8887 and via email at [email protected]. Learn More on John G. Saia's contact information.
Has John G. Saia been buying or selling shares of Guardant Health?: During the last quarter, John G. Saia has sold $865,865.00 in Guardant Health stock. Most recently, John G. Saia sold 8,996 shares of the business's stock in a transaction on Friday, November 7th. The shares were sold at an average price of $96.25, for a transaction totalling $865,865.00. Following the completion of the sale, the insider now directly owns 43,172 shares of the company's stock, valued at $4,155,305. Learn More on John G. Saia's trading history.
Who are Guardant Health's active insiders?: Guardant Health's insider roster includes Derek Bertocci (CFO), Ian Clark (Director), Helmy Eltoukhy (CEO), Medina Hidalgo (Director), Meghan Joyce (Director), Kumud Kalia (Insider), Samir Kaul (Director), Stanley Meresman (Director), Amelia Merrill (SVP), Terilyn Monroe (Insider), Myrtle Potter (Director), John Saia (Insider), Amirali Talasaz (COO), and Musa Tariq (Director). Learn More on Guardant Health's active insiders.
Are insiders buying or selling shares of Guardant Health?: During the last year, insiders at the sold shares 39 times. They sold a total of 975,960 shares worth more than $69,608,350.81. The most recent insider tranaction occured on December, 8th when CEO Amirali Talasaz sold 100,000 shares worth more than $10,505,000.00. Insiders at Guardant Health own 6.1% of the company. Learn More about insider trades at Guardant Health.
Information on this page was last updated on 12/8/2025.

John G. Saia Insider Trading History at Guardant Health

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
11/7/2025	Sell	8,996	$96.25	$865,865.00	43,172

John G. Saia Buying and Selling Activity at Guardant Health

Guardant Health Company Overview

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.

Today's Range

Now: $102.07

$100.47

$103.52

50 Day Range

MA: $88.71

$61.73

$111.25

2 Week Range

Now: $102.07

$29.91

$112.43

Volume

1,486,696 shs

Average Volume

2,172,761 shs

Market Capitalization

$12.86 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.58

John Saia Biography and Net Worth

What is John G. Saia's net worth?

How old is John G. Saia?

What is John G. Saia's salary?

How do I contact John G. Saia?

Has John G. Saia been buying or selling shares of Guardant Health?

Who are Guardant Health's active insiders?

Are insiders buying or selling shares of Guardant Health?